C肽和糖化血红蛋白联合检测对2型糖尿病诊断价值分析

Analysis of the Value of Combined C-Peptide and Glycosylated Haemoglobin Tests in the Diagnosis of Type 2 Diabetes

摘要: 目的：对血清C肽以及糖化血红蛋白在2型糖尿病中的诊断价值进行探究。方法：2021年4月至2021年10月大理大学第一附属医院收治的120例2型糖尿病患者作为实验组，并选取同一时期120名健康体检者作为对照组，实验组和对照组均检测血清C肽和糖化血红蛋白，并收集相关资料进行统计学分析。结果：与对照组相比，实验组2型糖尿病患者的糖化血红蛋白值明显升高，实验组血清C肽水平显著降低(P < 0.05)。结论：相较于健康体检者，2型糖尿病患者血清C肽水平明显降低，糖化血红蛋白水平明显升高，C肽和糖化血红蛋白联合检测有助于诊断2型糖尿病，具有较高的应用价值。

Abstract: Objective: To explore serum C-peptide combined glycosylated hemoglobin value in the diagnosis of type 2 diabetes. Methods: 120 patients with type 2 diabetes admitted to First Affiliated Hospital of Dali University from April 2021 to October 2021 were selected as the experimental group, and 120 healthy subjects during the same period were selected as the control group. Serum C-peptide and HbA1c were detected in both the experimental group and the control group, and relevant data were collected for statistical analysis. Results: Compared with the control group, the HbA1c value in the experimental group was significantly higher and the serum C-peptide level in the experimental group was significantly lower than that in the control group (P < 0.05). Conclusion: Patients with type 2 diabetes have significantly lower serum C-peptide levels and significantly higher glycosylated haemoglobin levels, compared to healthy subjects. The combined detection of the two indicators can provide reliable reference information for the screening and diagnosis of type 2 diabetes mellitus, and has high value.